Tetratherix Ltd

TTX · AU · Healthcare / Biotechnology

6.40AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close6.40

Open6.37

Day Range6.14 – 6.40

52-Week Range3.09 – 8.08

Volume15.00K

Market Cap351.78M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.18

Dividend Yield0.00%

50-Day Avg6.75

200-Day Avg5.36

About

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical devices in the areas of bone regeneration, tissue spacing, tissue regeneration, and precision medicine applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. William Anthony Knox
Employees25
HeadquartersUnit 29, Alexandria, NSW, Australia, 2015, Australia
Websitehttps://tetratherix.com

Leadership

Mr. William Anthony KnoxCEO, MD & Executive Director
Dr. Ali FathiFounder, CTO & Executive Director
Mr. Terence AbramsFounder & COO
Ms. Cherie BeachChief Financial Officer
Mr. Jacob PfefferChief of Staff, General Counsel & Company Secretary
Alex WashingtonFinancial Controller

Financials

Income Statement

Currency: AUD	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Revenue	566.28K	863.65K	1.14M	918.15K
Growth (%)	-	+52.51%	+32.30%	-19.65%
Cost of Revenue	1.15M	1.35M	3.11M	-
Gross Profit	-579.33K	-490.73K	-1.97M	918.15K
Gross Margin	-102.30%	-56.82%	-172.06%	100.00%
Operating Expense	1.11M	1.94M	7.38M	13.41M
Operating Income	-1.68M	-2.43M	-9.34M	-12.50M
Operating Margin	-297.49%	-281.85%	-817.74%	-1361.06%
EBITDA	-3.84M	-4.32M	-9.28M	-8.30M
EBITDA Margin	-678.11%	-499.74%	-811.93%	-903.48%
Net Income	-1.82M	-2.55M	-9.43M	-9.32M
Net Income Margin	-321.48%	-295.72%	-824.89%	-1015.14%
R&D	1.22M	1.91M	1.42M	2.46M
R&D as % of Total Revenue	215.09%	220.81%	124.16%	268.38%
Interest Expense	136.00K	120.00K	68.15K	98.58K
Interest Expense % of Total Revenue	24.02%	13.89%	5.96%	10.74%

Balance Sheet

Currency: AUD	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	1.40M	1.41M	31.83M	53.17M
Total Liabilities	5.95M	8.18M	4.59M	20.44M
Total Equity	-4.56M	-6.78M	27.25M	32.73M
Cash	260.58K	126.95K	29.34M	34.36M

Cash Flow

Currency: AUD	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Cash Flow	-388.24K	-2.56M	-2.67M	-
Investing Cash Flow	-4.99K	-36.03K	-594.83K	-
Financing Cash Flow	646.09K	2.42M	32.47M	13.62M
Capital Expenditure	4.99K	36.03K	594.83K	5.55M
Free Cash Flow	-2.55M	-4.53M	-3.27M	-7.93M
FCF to OCF	657.07%	176.81%	122.27%	-

Earnings

Report Date	Jun 13, 2025	Aug 27, 2025
EPS Estimate	0.00	0.00
EPS Actual	-55.01	-0.14
Surprise	-	-
Timing	-	-

Key Statistics & Ratios

Market Cap351.78M

Enterprise Value316.18M

Trailing P/E0.00

Forward P/E0.00

Price / Sales91.09

Price / Book10.38

EPS-0.18

Book Value0.617

Revenue (TTM)3.86M

Gross Profit (TTM)3.86M

EBITDA-9.42M

Profit Margin-241.36%

Operating Margin-194.52%

Return on Equity-31.08%

Return on Assets-14.05%

Shares Outstanding53.06M

Shares Float14.31M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%